Xenon Pharmaceuticals to Present at the Wells Fargo 2022 Healthcare Conference
02 September 2022 - 6:01AM
Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused
biopharmaceutical company, today announced that management will
participate in one-on-one investor meetings and a fireside chat
presentation at the 17th Annual Wells Fargo Securities Healthcare
Conference taking place in Everett, MA from September 7-9, 2022.
Fireside Chat Details:
|
Date: |
Thursday,
September 8, 2022 |
|
|
|
|
Time: |
11:35 am -12:05 pm ET |
|
|
|
|
Presenters: |
Ian
Mortimer, President and CEOChris Von Seggern, CCO |
A webcast of the fireside chat will be available
on the “Investors” section of Xenon's website at
investor.xenon-pharma.com. When available, webcasts will be posted
for replay following the event. The above listed dates and times
are subject to change.
About Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals (NASDAQ:XENE) is a
clinical stage biopharmaceutical company committed to developing
innovative therapeutics to improve the lives of patients with
neurological disorders. We are advancing a novel product pipeline
of neurology therapies to address areas of high unmet medical need,
with a focus on epilepsy. For more information, please visit
www.xenon-pharma.com.
“Xenon” and the Xenon logo are registered
trademarks or trademarks of Xenon Pharmaceuticals Inc. in various
jurisdictions. All other trademarks belong to their respective
owner.
Investor/Media Contact:Jodi RegtsXenon
Pharmaceuticals Inc.Phone: 604.484.3353Email:
investors@xenon-pharma.com
Xenon Pharmaceuticals (NASDAQ:XENE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Xenon Pharmaceuticals (NASDAQ:XENE)
Historical Stock Chart
From Apr 2023 to Apr 2024